ÂÜÀòÂÒÂ×

Matthew Bird is an accomplished professional in the biotech and pharmaceutical industries, currently serving as Associate Director and previously as Senior Scientist at ADC Therapeutics since July 2021. Prior roles include Scientific Fellow and Team Leader at Abzena from February 2012 to July 2021, as well as Senior Scientist and Research Scientist at PolyTherics Limited, an Abzena company, between February 2010 and January 2012. Earlier in the career, Matthew Bird worked as a Research Chemist at AstraZeneca from October 2003 to September 2004.